1Wall Me,Wani Mc,Cook CE,et al.The isolation and structure of camptothecin,a novel alkaloidal leukemia and tumor[J].J Am Chem Soc,1966,88 (16):3888-3890. 被引量：1
2Hsiang YH,Hertzberg R,Hecht S,et al.Camptothecin induces proteinlinked DNA breaks via mammalian DNA topoisomerase Ⅰ[J].Biolchem,1985,260(27):14873-14878. 被引量：1
3Kingsbury WD,Boehm JC,Jakas DR,et al.Synthesis of water-soluble (aminoalkyl) camptothecin analogues:inhibition of topoisomerase Ⅰ and antitumor activity[J].J Med Chem,1991,34(1):98-107. 被引量：1
4Negoro S,Fukuoka M,Masuda N,et al.Phase Ⅰ study of weekly intravenous infusions of CPT-11,a new derivative of camptothecin,in the treatment of advanced non-small-cell lung cancer[J].J Natl Cancer Inst,1991,83(6):1164-1168. 被引量：1
6Wani MC,Taylor HL,Wall ME,et al.Plant antitumor agents Ⅵ.The isolation and structure of taxol,a novel antileukemic and antitumor agent from Taxus brevifolia[J].J Am Chem Soc,1971,93(9):2325-2327. 被引量：1
9Lee KH,Wang KH.Current status of bioanalysis of etoposide and related compounds[J].J Food Drug Anal,1996,3(4):209-232. 被引量：1
10Wang HK,Morris-Natschke SL,Lee KH.Antitumor agents 170.recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents[J].Med Res Rev,1997,17(4):367-425. 被引量：1
二级参考文献33
1Verschraegen CF,Gupta E,Loyer E,et al.A phase Ⅱ clinical and pharmacological study of oral 9-nitrocamptothecin patents with refractory epithelial ovarian,tubal or peritoneal cancer[J].Anticancer Drugs,1999,10(4):375-383. 被引量：1
2Adil D,Nikola V,Barbara C,et al.Phase Ⅱ Trial of Karenitecin in Patients with Malignant Melanoma:Clinical and Translational Study[J].Clin Cancer Res,2005,1 (11):3009-3016. 被引量：1
3Petrangolini G,Pratesi G,De-Cesare M,et al.Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts[J].Mol Cancer Res,2003,1 (12):863-870. 被引量：1
4Mitsui I,Kumazawa E,Hirota Y,et al.A new watersoluble camptothecin derivative,DX-8951f,exhibits potent antitumor activity against human tumors in vitro and in vivo[J].Jpn J Cancer Res,1995,86(8):776-782. 被引量：1
5Luzzio MJ,Besteman JM,Emerson DL,et al.Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase Ⅰ[J].J Med Chem,1995,38(3):395 -401. 被引量：1
7Ulukan H,Swan PW.Camptothecin:a review of their chemotherapeutical potential[J].Drugs,2002,62 (4):2 039-2 057. 被引量：1
8Bhatt R,De Vries P,Tulinsky J,et al.Synthesis and in vivo antitumor activity of poly (L-glutamic acid) conjugates of 20 (S)-camptothecin[J].J Med Chem,2003,46 (1):190-193. 被引量：1
9Lerchen HG,Baumgarten J.Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents[J].J Med Chem,2001,44(24):4 186-4 195. 被引量：1
10Angenault S,Thirot S,Schmidt F,et al.Cancer chemotherapy:a SN -38(7-ethyl-10-hydroxycamptothecin) glucuronide for treatment by a PMT(prodrug monotherapy)strategy[J].Bioorg Med Chem Lett,2003,13(5):947-950. 被引量：1
